DarioHealth
DRIO
58 hedge funds and large institutions have $162M invested in DarioHealth in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 20 closing their positions.
175% more capital inflows, than outflows
Capital inflows: $63M | Capital outflows: $22.9M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
64% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 11
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
12.88% more ownership
Funds ownership: 35.8% → 48.68% (+13%)
7% more funds holding
Funds holding: 54 → 58 (+4)
3% less call options, than puts
Call options by funds: $1.65M | Put options by funds: $1.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14M |
| 2 |
Collaborative Holdings Management
New York
|
+$9.7M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$6.61M |
| 4 |
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.96M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pura Vida Investments
New York
|
-$6.86M |
| 2 |
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.44M |
| 3 |
Essex Investment Management
Boston,
Massachusetts
|
-$2.61M |
| 4 |
Meitav Investment House
Bene-Beraq,
Israel
|
-$1.66M |
| 5 |
Farallon Capital Management
San Francisco,
California
|
-$1.14M |
DRIO Hedge Fund Activity: Q2 2021 in Review
58 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2021, worth a combined $162M — up 54% from $105M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new DRIO positions and 20 closed out — a net gain of 4 holders — while 18 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $14M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $6.86M sold.
- 58 institutional investors held DarioHealth (DRIO) as of Q2 2021, up from 54 in Q1 2021.
- Funds reported $162M of DarioHealth stock for Q2 2021, up 54% quarter-over-quarter.
- 24 funds opened new DarioHealth positions in Q2 2021 and 20 closed out, a net change of +4 holders.
- The largest DarioHealth buyer in Q2 2021 was BlackRock, an estimated $14M added.
- The largest DarioHealth seller in Q2 2021 was Pura Vida Investments, an estimated $6.86M sold.
Based on aggregated 13F filings for Q2 2021.